Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 4425 is a non-coding RNA molecule classified as a microRNA. In humans, microRNAs are typically 20–24 nucleotides in length, transcribed from DNA but not translated into protein. Instead, they bind target messenger RNAs at partially complementary sites—usually in the 3' untranslated regions—and downregulate gene expression by promoting mRNA degradation or inhibiting translation initiation. MicroRNAs are implicated in the fine tuning of protein outputs, cell differentiation, proliferation, and robustness against environmental perturbations. Their abnormal regulation is widely associated with disease, especially cancer and metabolic disorders. Individual microRNAs may be leveraged as diagnostic markers or therapeutic targets, but specific disease roles for miR-4425 itself are currently undefined in the literature.
Gene silencing via mRNA degradation or translational repression Regulation of biological pathways through targeting specific mRNAs
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 4425 (miR-4425).